Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients

S Tigaran1, H Mølgaard, R McClelland

  • 1Department of Neurology, Aarhus University Hospital, Aarhus, Denmark. mona@akhphd.au.dk

Neurology
|February 13, 2003
PubMed

Insights

Patients with drug-resistant epilepsy may experience cardiac ischemia, indicated by ST-segment depression during seizures. This finding suggests a potential link between epilepsy and cardiovascular abnormalities, contributing to sudden death risk.

Area of Science:

  • Cardiology
  • Neurology
  • Epileptology

Background:

  • Epilepsy is associated with an increased risk of sudden unexpected death.
  • Cardiovascular abnormalities may contribute to this risk in patients with drug-refractory epilepsy.

Purpose of the Study:

  • To investigate cardiovascular abnormalities in patients with drug-refractory epilepsy.
  • To explore the potential link between these abnormalities and sudden death risk.

Main Methods:

  • Twenty-three patients with drug-refractory epilepsy underwent cardiovascular evaluations.
  • Evaluations were conducted before and during video-electroencephalogram (EEG) monitoring.

Main Results:

  • ST-segment depression, indicative of cardiac ischemia, occurred in 40% of patients.
  • ST-segment depression was associated with higher maximum heart rates during seizures.

Conclusions:

  • Cardiac ischemia may occur in patients with drug-refractory epilepsy.
  • These findings suggest a potential mechanism for cardiovascular events and sudden death in this population.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...